Stocks and Investing
Stocks and Investing
Thu, March 12, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Paul Matteis Initiated (AVDL) at Strong Buy and Held Target at $14 on, Mar 12th, 2020
Paul Matteis of Stifel, Initiated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $14 on, Mar 12th, 2020.
Paul has made no other calls on AVDL in the last 4 months.
There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 0 agree with Paul's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Paul
- David Amsellem of "Piper Sandler" Initiated at Buy and Held Target at $14 on, Wednesday, February 26th, 2020
- Francois Brisebois of "Craig-Hallum" Initiated at Strong Buy and Held Target at $15 on, Thursday, January 30th, 2020